Synthetic Lethal Targeting of CDK12-Deficient Prostate Cancer with PARP Inhibitors.
Chou J, Robinson TM, Egusa EA, Lodha R, Zhang M, Badura M, Mikayelyan M, Delavan HM, Swinderman J, Wilson C, Zhu J, Das R, Nguyen M, Loehr A, Golsorkhi T, Simmons A, Abida W, Chinnaiyan AM, Arkin MR, Small EJ, Quigley DA, Yang L, Kim M, Ashworth A, Feng FY.
Chou J, et al. Among authors: arkin mr.
Clin Cancer Res. 2024 Dec 2;30(23):5445-5458. doi: 10.1158/1078-0432.CCR-23-3785.
Clin Cancer Res. 2024.
PMID: 39321214